The Department of Biochemistry and Biotechnology (DBB) at the University of Thessaly reinforces its leadership not only in research but also in education within the rapidly evolving field of Synthetic Biology, through the launch of a new international Master’s program in collaboration with the world-renowned McGill University in Canada.
This new postgraduate program crowns the Department’s long-standing, strategic investment in the development of Synthetic Biology. From incorporating relevant courses into both undergraduate and graduate curricula, to coordinating the National Research Infrastructure OMIC-Engine, DBB has consistently fostered a field that bridges biology with engineering, informatics, and biotechnology—advancing interdisciplinary innovation and strengthening the bioeconomy.
The newly approved Master’s program is the only one in Synthetic Biology currently offered by a Greek university. Its establishment, within the national initiative “Internationalization of Higher Education Services,” is supported by substantial funding from the Recovery and Resilience Facility. This milestone further enhances the international standing of both the DBB and the University of Thessaly, positioning the region of Thessaly as a hub of high-tech education, innovation, and global outreach in a cutting-edge scientific field.
Under the same initiative, two additional international Master’s programs of the University of Thessaly have also been approved: “Humanitarian Action and Inclusive Management of Public and One Health Challenges” (a collaboration between the UTh Department of Veterinary Medicine and Columbia University, USA) and “Joint Executive Master’s Program in Leadership Education in Disability and Inclusion” (collaboration between the UTh Department of Special Education and Georgetown University, USA).